Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(78)
Alan Ashworth
15
Christopher J. Lord
9
Jorge Sergio Reis-Filho
8
Andrew N. J. Tutt
8
Elizabeth Iorns
6
Journals
(21)
CLIN CANCER RES
2
NAT REV CANCER
2
Oncogene
2
PLOS One
2
Cancer Cell
1
Keywords
(72)
Embed
Subscribe
Academic
Authors
Nicholas C. Turner
Nicholas C. Turner,University of Manitoba,Oncology,Pharmacology,Cell Biology
Edit
Nicholas C. Turner
University of Manitoba
Publications:
26
|
Citations:
876
Fields:
Oncology
,
Pharmacology
,
Cell Biology
View FAQ about top research areas and Fields of study
Collaborated with
78 co-authors
from 1995 to 2012
|
Cited by
2864 authors
Cumulative
Annual
Sort by:
Publications
(26)
BibTeX
|
RIS
|
RefWorks
Download
Transformational leadership and employee psychological well-being: The mediating role of employee trust in leadership
E. Kevin Kelloway
,
Nick Turner
,
Julian Barling
,
Catherine Loughlin
Journal:
Work and Stress - WORK STRESS
, vol. 26, no. 1, pp. 39-55, 2012
Perceptions of the presence and effectiveness of high involvement work systems and their relationship to employee attitudes : A test of competing models
Morris B. Mendelson
,
Nick Turner
,
Julian Barling
Journal:
Personnel Review - PERS REV
, vol. 40, no. 1, pp. 45-69, 2011
Biomarkers of PARP inhibitor sensitivity
Nicholas C. Turner
,
Alan Ashworth
Journal:
Breast Cancer Research and Treatment - BREAST CANCER RES TREAT
, vol. 127, no. 1, pp. 283-286, 2011
Fibroblast growth factor signalling: from development to cancer
(
Citations: 42
)
Nicholas Turner
,
Richard Grose
Journal:
Nature Reviews Cancer - NAT REV CANCER
, vol. 10, no. 2, pp. 116-129, 2010
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
(
Citations: 8
)
N. Turner
,
A. Pearson
,
R. Sharpe
,
M. Lambros
,
F. Geyer
,
M. A. Lopez-Garcia
,
R. Natrajan
,
C. Marchio
,
E. Iorns
,
A. Mackay
,
C. Gillett
,
A. Grigoriadis
http://academic.research.microsoft.com/io.ashx?type=5&id=31541155&selfId1=53821098&selfId2=0&maxNumber=12&query=
Journal:
Cancer Research - CANCER RES
, vol. 70, no. 5, pp. 2085-2094, 2010
Sort by:
Citations
(876 times by 638 publications)
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Courtney A. Lovejoy
,
Wendi Li
,
Steven Reisenweber
,
Supawat Thongthip
,
Joanne Bruno
,
Titia de Lange
,
Saurav De
,
John H. J. Petrini
,
Patricia A. Sung
,
Maria Jasin
,
Joseph Rosenbluh
,
Yaara Zwang
http://academic.research.microsoft.com/io.ashx?type=5&id=57410005&selfId1=53821098&selfId2=0&maxNumber=12&query=
Journal:
PLOS Genetics - PLOS GENET
, vol. 8, no. 7, 2012
Epigenetic Drug Discovery: Targeting DNA Methyltransferases
Jason M. Foulks
,
K. Mark Parnell
,
Rebecca N. Nix
,
Suzanna Chau
,
Krzysztof Swierczek
,
Michael Saunders
,
Kevin Wright
,
Thomas F. Hendrickson
,
Koc-Kan Ho
,
Michael V. McCullar
,
Steven B. Kanner
Journal:
Journal of Biomolecular Screening - J BIOMOL SCREEN
, vol. 17, no. 1, pp. 2-17, 2012
Distinct patterns of promoter CpG island methylation of breast cancer subtypes are associated with stem cell phenotypes
So Yeon Park
,
Hyeong Ju Kwon
,
Yoomi Choi
,
Hee Eun Lee
,
Sung-Won Kim
,
Jee Hyun Kim
,
In Ah Kim
,
Namhee Jung
,
Nam-Yun Cho
,
Gyeong Hoon Kang
Journal:
Modern Pathology - MODERN PATHOL
, vol. 25, no. 2, pp. 185-196, 2012
Lack of Effect of Brivanib on the Pharmacokinetics of Midazolam, a CYP3A4 Substrate, Administered Intravenously and Orally in Healthy Participants
Shariq Syed
,
Pamela L. Clemens
,
Deanne Lathers
,
Georgia Kollia
,
Arindam Dhar
,
Ian Walters
,
Eric Masson
Journal:
Journal of Clinical Pharmacology - J CLIN PHARMACOL
, vol. 52, no. 6, pp. 914-921, 2012
The potential of exploiting DNA-repair defects for optimizing lung cancer treatment
Sophie Postel-Vinay
,
Elsa Vanhecke
,
Ken A. Olaussen
,
Christopher J. Lord
,
Alan Ashworth
,
Jean-Charles Soria
Journal:
Nature Reviews Clinical Oncology - NAT REV CLIN ONCOL
, vol. 9, no. 3, pp. 144-155, 2012
Comments